(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.35%) $79.23
(0.20%) $2.04
(0.16%) $2 313.30
(0.38%) $26.93
(0.20%) $964.50
(0.00%) $0.932
(-0.09%) $10.98
(-0.04%) $0.798
(0.03%) $91.15
Live Chart Being Loaded With Signals
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies...
Stats | |
---|---|
Šios dienos apimtis | 74 280.00 |
Vidutinė apimtis | 218 908 |
Rinkos kapitalizacija | 32.00B |
EPS | HKD0 ( 2023-10-30 ) |
Last Dividend | HKD1.983 ( 2023-06-15 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 11.62 |
ATR14 | HKD0.0540 (0.08%) |
Tūris Koreliacija
Asymchem Laboratories Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Asymchem Laboratories Koreliacija - Valiuta/Žaliavos
Asymchem Laboratories Finansinės ataskaitos
Annual | 2023 |
Pajamos: | HKD7.83B |
Bruto pelnas: | HKD4.00B (51.16 %) |
EPS: | HKD6.26 |
FY | 2023 |
Pajamos: | HKD7.83B |
Bruto pelnas: | HKD4.00B (51.16 %) |
EPS: | HKD6.26 |
FY | 2022 |
Pajamos: | HKD10.26B |
Bruto pelnas: | HKD4.86B (47.37 %) |
EPS: | HKD9.02 |
Financial Reports:
No articles found.
Asymchem Laboratories Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD1.983 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.671 | 2022-06-13 |
Last Dividend | HKD1.983 | 2023-06-15 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD2.65 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.38 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.14 | |
Div. Directional Score | 9.55 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2888.HK | Ex Dividend Junior | 2023-08-10 | Annually | 0 | 0.00% | |
1508.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
0558.HK | Ex Dividend Junior | 2023-09-12 | Annually | 0 | 0.00% | |
8095.HK | Ex Dividend Junior | 2023-10-17 | Sporadic | 0 | 0.00% | |
2009.HK | No Dividend Player | 2023-05-18 | Annually | 0 | 0.00% | |
1084.HK | Ex Dividend Junior | 2023-06-06 | Semi-Annually | 0 | 0.00% | |
0158.HK | Ex Dividend Junior | 2023-06-15 | Semi-Annually | 0 | 0.00% | |
3698.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
1658.HK | Ex Dividend Junior | 2023-07-05 | Annually | 0 | 0.00% | |
0697.HK | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.275 | 1.500 | 4.49 | 6.74 | [0 - 0.5] |
returnOnAssetsTTM | 0.0968 | 1.200 | 6.77 | 8.13 | [0 - 0.3] |
returnOnEquityTTM | 0.111 | 1.500 | 9.88 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0282 | -1.000 | 9.72 | -9.72 | [0 - 1] |
currentRatioTTM | 6.85 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 6.18 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.27 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00724 | -1.500 | 9.88 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 350.89 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.05 | 2.00 | 7.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.67 | 2.00 | 8.66 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00817 | -1.500 | 9.97 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.505 | 1.000 | 4.91 | 4.91 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.309 | 1.000 | 5.82 | 5.82 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 15.65 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.352 | 0.800 | -0.989 | -0.792 | [0.5 - 2] |
Total Score | 12.95 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.56 | 1.000 | 8.93 | 0 | [1 - 100] |
returnOnEquityTTM | 0.111 | 2.50 | 9.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.67 | 2.00 | 9.11 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.31 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.05 | 2.00 | 7.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0282 | 1.500 | 9.72 | -9.72 | [0 - 1] |
pegRatioTTM | 0.301 | 1.500 | -1.326 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.322 | 1.000 | 4.45 | 0 | [0.1 - 0.5] |
Total Score | 6.14 |
Asymchem Laboratories
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.